These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 27816952

  • 1. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
    Hoxha A, Mattia E, Tonello M, Grava C, Pengo V, Ruffatti A.
    Clin Chem Lab Med; 2017 May 01; 55(6):890-898. PubMed ID: 27816952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M, Natorska J, Undas A.
    Lupus; 2018 Apr 01; 27(5):812-819. PubMed ID: 29338587
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.
    Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.
    Arthritis Care Res (Hoboken); 2018 Apr 01; 70(4):627-634. PubMed ID: 28686816
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E, Darnige L, Kirilovsky A, Burnel Y, de Luna G, Dragon-Durey MA.
    Front Immunol; 2018 Apr 01; 9():2971. PubMed ID: 30619328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M, Celińska-Löwenhoff M, Plens K, Iwaniec T, Musiał J, Undas A.
    J Thromb Haemost; 2019 Oct 01; 17(10):1746-1755. PubMed ID: 31220407
    [Abstract] [Full Text] [Related]

  • 16. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML.
    Thromb Haemost; 2014 Feb 01; 111(2):354-64. PubMed ID: 24172938
    [Abstract] [Full Text] [Related]

  • 17. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A, Chayoua W, de Laat B, Moore GW, Musiał J, Zuily S, Wahl D, Devreese KMJ.
    J Thromb Haemost; 2022 Sep 01; 20(9):2136-2150. PubMed ID: 35713971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.
    Clin Exp Immunol; 2015 May 01; 180(2):218-26. PubMed ID: 25522978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.